INTERVIEW: Russian medtech industry keeps close watch on pace of regulatory reform
This article was originally published in Clinica
A lot has happened to reshape Russia’s medical devices regulatory system within a very short time. Credit is due to the health ministry and Roszdravnadzor, the healthcare regulatory and surveillance agency, for embarking on the changes – however rocky the path has been at times. But it’s not the finished article, and industry will keep up the pressure in bid to secure a workable and forward-looking system, as IMEDA executive director Alexandra Tretiakova tells Ashley Yeo
You may also be interested in...
RSNA is the next major global medtech event to be run under a virtual format this fall. Under COVID-19, the major medtechs are finding different ways to demonstrate value, as Royal Philips explains.
The RSNA is the next global medtech exhibition and conference event to be run under a virtual format this fall.
COVID-19 put a dampener on Conmed’s 50th anniversary of operations, but CFO Todd Garner says the company is poised to resume its growth strategy, post-pandemic.